Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Adalimumab

Australian Public Assessment Report

AusPAR

AusPAR: Adalimumab [PDF, 469.68 KB]

AusPAR: Adalimumab [DOCX, 481.6 KB]

Attachment: Extract from the Clinical Evaluation Report: Adalimumab [PDF, 794.69 KB]

Attachment: Extract from the Clinical Evaluation Report: Adalimumab [DOCX, 1.34 MB]

Device/Product Name

Humira

Active ingredients

Adalimumab

AusPAR Date

22 January 2014

Published

31 March 2014

Submission Number

PM-2012-02255-3-3

Submission Type

Extension of indications

Decision

Withdrawn

Product types

Prescription medicines